3 Stocks Poised to Disrupt the Healthcare Market by 2030
The biggest mistake investors make with healthcare stocks is assuming the future will look like the past: incremental…
How some COVID vaccines triggered rare blood-clot disorder
Many countries changed their advice about who should have the AstraZeneca vaccine (pictured) following reports it could trigger…
BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®
BioXcel Therapeutics Company remains focused on potential approval and launch of IGALMI® for the acute treatment of agitation…
Longevity therapeutics market to double by 2033
Global longevity therapeutics market projected to hit US$43.72b by 2033, as supplements and antiaging solutions move from niche…
Single antivenom protects against 17 different snakebites
The black mamba is one Africa’s most deadly venomous snakes.Credit: Matthijs Kuijpers/Alamy An antivenom using antibodies from a…
Elevara Medicines Raises $70 Million Series A to Advance
Co-led by Forbion and Sofinnova Partners, along with founding investor Monograph Capital, and Weatherden Innovative lead program, ELV001,…
AI-designed proteins revolutionize gene editing precision and safety
Researchers at Integra Therapeutics, in collaboration with the Pompeu Fabra University (UPF) Department of Medicine and Life Sciences…
Controversial New Alzheimer’s Drugs Offer Hope—But at a High Cost
One of neurologist Anelyssa D’Abreu’s least favorite tasks is giving her patients a dreaded diagnosis: early-stage Alzheimer’s disease.…
Enhanced Genomics extends Series A funding to USD $19 million to drive development of therapeutics pipeline
Enhanced Genomics (‘Enhanced’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for…
should research on mirror-image molecular biology be stopped?
In theory, all biological structures, functions and even organisms could be recreated in their mirror image, leading to…